Total Funding
19
47
Total FundingConvertible Note raised
Growth Score
-25 pts
Heat Score
-13 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
40427
Aptimmune is a biotechnology company that specializes on developing mucosal vaccines for swine.
Federico Zuckermann: Founder & Chief Scientific Officer- Heather Bessoff: CEO
About the Company
Aptimmune is a biotechnology company that focuses on developing a muscoal vaccine against viral diseases swine. It focuses on swine vaccines and the prevention of two major diseases, Porcine Reproductive and Respiratory Syndrome virus (PRRSV) and influenza. It utilizes novel technologies to create effective nasal delivery vaccines against PRRSV
such as the proprietary pig alveolar macrophage cell line ZMAC.
The company was founded in 2010 and headquartered in St. Louis, Missouri.
Hispanic / Latine Founded
Hispanic / Latine Led
Women Founded
Women Led
